Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest ACell Stories

2014-03-31 08:30:30

New contract broadens access of MatriStem to an additional 100,000 healthcare entities COLUMBIA, Md., March 31, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has entered into a national purchasing agreement with Novation for the Company's MatriStem® devices. The MatriStem devices also were awarded the elite Innovative Technology...

2014-03-26 08:29:41

CME-credited Event to Leverage Broad UBM Clinical Experience for Expanded Awareness COLUMBIA, Md., March 26, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it will sponsor a continuing medical education (CME) credited lecture at the upcoming Academy of Physicians in Wound Healing (APWH) 2014 Annual Conference taking place March 27-30 in...

2014-02-10 08:27:05

Solution for deep, hard-to-heal wounds with additional contouring functionality COLUMBIA, Md., Feb. 10, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has launched the new MatriStem® Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds. The one-to-one (1:1) mesh design of MatriStem Multilayer Wound Matrix is built to...

2014-02-05 08:29:47

Offers broad range of regenerative therapy solutions COLUMBIA, Md., Feb. 5, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has expanded the MatriStem® Pelvic Floor Matrix product portfolio with the addition of four device sizes. The addition of four new sizes to the portfolio offers a broad range of viable solutions for physicians treating...

2014-01-13 08:29:02

COLUMBIA, Md., Jan. 13, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced it has initiated, with multiple patients enrolled, a U.S. post-market clinical trial (NCT01858545) comparing the efficacy of MatriStem® to a leading cellular scaffold, Dermagraft®, for the treatment of patients with diabetic foot ulcers (DFUs) that failed to adequately heal...

2013-12-09 20:23:00

In the news release, ACell Nearly Doubles Board of Directors with Addition of Three Members, issued 09-Dec-2013 by ACell, Inc. over PR Newswire, we are advised by the company that the release should state that Jon T. Tremmel held several senior leadership positions with Medtronic, Inc. rather than serving as a board director of Medtronic as originally issued inadvertently. The complete, corrected release follows: ACell Nearly Doubles Board of Directors with Addition of Three Members Adds...

2013-12-09 08:28:37

Adds Significant Financial and Healthcare Expertise; Expands Board from Four Members to Seven COLUMBIA, Md., Dec. 9, 2013 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced that it has nearly doubled the size of its Board of Directors with the appointment of three members. The additions of Jon T. Tremmel, Steven P. Mullins and James D'Orta, M.D. increase the...

2013-10-25 12:24:00

COLUMBIA, Md., Oct. 25, 2013 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of surgical and wound management products, today announced that it has broken ground on the expansion of its manufacturing facility in Lafayette, Indiana to support the Company's current and anticipated growth. The 14,000 square-foot addition to the current building will increase scalability and efficiency of ACell's...

2013-07-09 08:28:55

Educational Courses, Hands-on Training and Peer-to-peer Events Designed to Drive Adoption of MatriStem® for Multiple Indications COLUMBIA, Md., July 9, 2013 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development and commercialization of unique extracellular matrix products, announced today the launch of a national physician education initiative consisting of educational courses, hands-on training, and peer-to-peer events. The Company is...

2013-05-15 12:33:58

COLUMBIA, Md., May 15, 2013 /PRNewswire/ -- ACell, Inc., a leading developer of next-generation regenerative medicine products, announced today that its MatriStem medical devices demonstrate the highest constructive remodeling response in a recent study comparing 14 extracellular matrices (ECM) designed to aid in surgical procedures. The study, "Macrophage phenotype as a predictor of constructive remodeling following the implantation of biologically derived surgical mesh materials," by Bryan...